MDX-1303 Completed Phase 1 Trials for Anthrax Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01265745 | Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects |